Nephros (NEPH)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.46 mm	2.46 mm	2.46 mm	2.46 mm	2.46 mm	2.46 mm
Cash burn (monthly)	207.67 k	180.42 k	(no burn)	80.00 k	207.67 k	171.67 k
Cash used (since last report)	835.25 k	725.65 k	n/a	321.76 k	835.25 k	690.45 k
Cash remaining	1.62 mm	1.73 mm	n/a	2.14 mm	1.62 mm	1.77 mm
Runway (months of cash)	7.8	9.6	n/a	26.7	7.8	10.3

Beta Read what these cash burn values mean

Financial data from Nephros earnings reports.

Institutional ownership, Q3 2023

NEPH institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	185	184	+0.5%
Opened positions	27	32	-15.6%
Closed positions	26	27	-3.7%
Increased positions	76	67	+13.4%
Reduced positions	59	58	+1.7%

13F shares	Current	Prev Q	Change
Total value	884.57 bn	1.24 tn	-28.6%
Total shares	64.66 mm	64.84 mm	-0.3%
Total puts	2.60 k	900.00	+188.9%
Total calls	3.10 k	4.10 k	-24.4%
Total put/call ratio	0.8	0.2	+282.1%

Largest owners	Shares	Value	Change
ATEYY Advantest	33.07 mm	$802.59 mm	0.0%
BLK BlackRock	4.66 mm	$150.88 bn	-1.1%
Vanguard	2.93 mm	$94.91 bn	+13.7%
Kibarian John Kachig	2.51 mm	$0.00	0.0%
IVZ Invesco	2.44 mm	$79.12 bn	-25.4%
Kimon Michaels	1.62 mm	$13.62 mm	0.0%
Snyder Capital Management L P	1.17 mm	$37.84 bn	-2.2%
Wasatch Advisors	1.15 mm	$37.11 bn	+8.1%
Samjo Capital	1.10 mm	$35.68 bn	+102.1%
STT State Street	1.05 mm	$34.06 bn	+3.0%

Largest transactions	Shares	Bought/sold	Change
Cowen Prime Advisors	0.00	-940.18 k	EXIT
IVZ Invesco	2.44 mm	-832.48 k	-25.4%
Samjo Capital	1.10 mm	+556.23 k	+102.1%
Vanguard	2.93 mm	+353.24 k	+13.7%
Arrowstreet Capital, Limited Partnership	66.45 k	-265.91 k	-80.0%
Thrivent Financial For Lutherans	233.14 k	+204.54 k	+715.0%
Ranger Investment Management	516.26 k	+193.32 k	+59.9%
ArrowMark Colorado	0.00	-171.00 k	EXIT
William Blair Investment Management	555.90 k	-141.32 k	-20.3%
Silvercrest Asset Management	194.08 k	+124.51 k	+179.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

NEPH insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
1 Jan 25	Joseph Michael Harris	Stock Option Common Stock	Grant	Acquire A	No	No	1.47	7,050	10.36 k	7,050
1 Jan 25	Alisa Lask	Stock Option Common Stock	Grant	Acquire A	No	No	1.47	7,050	10.36 k	7,050
1 Jan 25	Oliver J. Spandow	Common Stock	Grant	Acquire A	No	No	0	33,241	0.00	114,845
1 Jan 25	Oliver J. Spandow	Stock Option Common Stock	Grant	Acquire A	No	No	1.47	7,050	10.36 k	7,050
1 Jan 25	Amron Arthur H	Common Stock	Grant	Acquire A	No	No	0	22,418	0.00	125,881
1 Jan 25	Amron Arthur H	Stock Option Common Stock	Grant	Acquire A	No	No	1.47	7,050	10.36 k	7,050
30 May 24	Amron Arthur H	Common Stock	Buy	Acquire P	No	No	2.2449	3,000	6.73 k	103,463
28 May 24	Amron Arthur H	Common Stock	Buy	Acquire P	No	No	2.2207	2,000	4.44 k	100,463

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Benchmark Reiterates Speculative Buy on Nephros, Maintains $5 Price Target

12 Nov 24

Benchmark analyst Robert Wasserman reiterates Nephros (NASDAQ:NEPH) with a Speculative Buy and maintains $5 price target.

Nephros Q3 2024 GAAP EPS $0.02 Beats $(0.02) Estimate, Sales $3.500M Beat $3.499M Estimate

7 Nov 24

Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. The company reported quarterly sales of $3.500 million which beat the analyst

Nephros Q3 Sales $3.50M Inline

7 Nov 24

Nephros (NASDAQ:NEPH) reported quarterly sales of $3.50 million which met the analyst consensus estimate. This is a 6.47 percent decrease over sales of $3.74 million the same period last year.

Press releases

From Benzinga Pro

Nephros Announces Financial Results for Quarter Ended September 30, 2024

7 Nov 24

Third-Quarter Net Revenue of $3.5 Million;Operational Improvements Result In First Profitable Quarter SOUTH ORANGE, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology